Boehringer Ingelheim completes $76-million expansionOctober 14, 2019Boehringer Ingelheim revealed a $76-million expansion at its manufacturing plant in Athens, Ga., that will double the company’s capacity to produce vaccines for pets.
SPONSORED CONTENTHelping manage the hidden signs of stressOur therapeutic nutrition targets underlying stress in cats with GI or urinary issues — helping provide relief to pets and their humans. + Learn More